Inovio Pharma Stock
Inovio Pharma Stock
The sentiment is rather negative at the moment with 6 Sell predictions and 2 Buy predictions.
On the other hand, the target price of 11 € is above the current price of 0.53 € for Inovio Pharma, so the potential is actually 1967.67%.
Our community identified positive and negative aspects for Inovio Pharma stock for the coming years. 1 users see the criterium "Business model" as a plus for the Inovio Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Inovio Pharma in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Inovio Pharma vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Inovio Pharma | - | - | - | - | - | - | - |
Ardelyx Inc. | -1.500% | -3.012% | 18.340% | 119.939% | 24.810% | 27.681% | - |
Evolus Inc | -1.630% | 4.310% | 14.151% | 34.444% | 33.702% | 59.211% | - |
Salarius Pharmaceuticals Inc. | 0.970% | -1.887% | -0.952% | -63.826% | -25.045% | -98.487% | -99.993% |
Comments
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at Stephens. They set an "overweight" rating and a $20.00 price target on the stock.
Show more
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $4.00 price target on the stock.
Show more
Ratings data for INO provided by MarketBeat